News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 279463

Wednesday, 11/23/2016 1:19:18 PM

Wednesday, November 23, 2016 1:19:18 PM

Post# of 347009

demonstrate that to the FDA with a clinical trial that has a NORMAL control arm.



Is it possible....if Peregrine has collaborations with a Biotech "X" and their collaboration is based on sharing profits 50/50 if FDA approved ....that Peregrine allows that Biotech "X"to possibly file for a BTD based on that combo and that way....less chance of interference from outside parties....

... and take it one step further is it possible their may be a biotech out there in a trial using some PS Targeting drug but it is called something else to keep all attention away...

Peregrine seems very clever to make a good PR sound dull and boring so now I ask questions like this where if they are really clever and keep the spotlight away from some trial that ultimately is a PS Targeting drug ...

Hmmmm...almost the same as Mr Warren Buffet where he buys/accumulates stocks while having SEC approval to keep the spotlight away from him while he is accumulating ....

Certainly a plan has been in place ....for quite some time now

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y